OTCMKTS:ABMC - American Bio Medica Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0750 0.00 (0.00 %)
(As of 05/23/2019 02:57 PM ET)
Previous Close$0.0750
Today's Range$0.07 - $0.0821
52-Week Range$0.0410 - $0.1250
Volume48,453 shs
Average Volume2,751 shs
Market Capitalization$2.44 million
P/E RatioN/A
Dividend YieldN/A
American Bio Medica Corporation develops, manufactures, and sells lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids at the point of collection. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; Rapid ONE product line that consists of single drug tests, each of which tests for the presence or absence of a single drug; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 2 to 10 drugs; Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 14 drugs; and Rapid TOX Cup II (2G), a second generation of the original Rapid TOX Cup II, which consists of a smaller cup with smaller test strip, as well as private labeled versions of Rapid TOX. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse; and products that detect the presence or absence of alcohol, and alternative sample options for drug testing, as well as toxicology management services. Further, it provides bulk test strip contract manufacturing services to non-affiliated diagnostic companies. American Bio Medica Corporation serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets in the United States and internationally. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was founded in 1986 and is based in Kinderhook, New York.

Receive ABMC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABMC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:ABMC



Sales & Book Value

Annual Sales$3.87 million
Book Value($0.01) per share


Net Income$-1,030,000.00


Market Cap$2.44 million
Next Earnings Date5/27/2019 (Estimated)
OptionableNot Optionable

American Bio Medica (OTCMKTS:ABMC) Frequently Asked Questions

What is American Bio Medica's stock symbol?

American Bio Medica trades on the OTCMKTS under the ticker symbol "ABMC."

How were American Bio Medica's earnings last quarter?

American Bio Medica Co. (OTCMKTS:ABMC) announced its quarterly earnings data on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The business earned $1.04 million during the quarter. American Bio Medica had a negative net margin of 26.78% and a negative return on equity of 793.89%. View American Bio Medica's Earnings History.

When is American Bio Medica's next earnings date?

American Bio Medica is scheduled to release their next quarterly earnings announcement on Monday, May 27th 2019. View Earnings Estimates for American Bio Medica.

Has American Bio Medica been receiving favorable news coverage?

News coverage about ABMC stock has trended somewhat positive this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. American Bio Medica earned a news impact score of 0.7 on InfoTrie's scale. They also gave headlines about the company a news buzz of 7.0 out of 10, indicating that recent press coverage is likely to have an impact on the company's share price in the immediate future.

Who are some of American Bio Medica's key competitors?

What other stocks do shareholders of American Bio Medica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Bio Medica investors own include Opko Health (OPK), Canadian Western Bank (CWB), DuPont Fabros Technology (DFT), Gilead Sciences (GILD), EXACT Sciences (EXAS), Erie Indemnity (ERIE), Celldex Therapeutics (CLDX), CoLucid Pharmaceuticals (CLCD), ChemoCentryx (CCXI) and Atrion (ATRI).

Who are American Bio Medica's key executives?

American Bio Medica's management team includes the folowing people:
  • Ms. Melissa A. Waterhouse, CEO, Principal Financial Officer & Director (Age 48)
  • Ms. Jean Neff, Corp. Sec. & Independent Director (Age 76)
  • Mr. Douglas Casterlin, VP of Operations (Age 71)
  • Dr. Scott D. Hutton, VP of Sales & Marketing (Age 62)
  • Mr. J. Duncan Urquhart, Controller (Age 65)

How do I buy shares of American Bio Medica?

Shares of ABMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is American Bio Medica's stock price today?

One share of ABMC stock can currently be purchased for approximately $0.0750.

How big of a company is American Bio Medica?

American Bio Medica has a market capitalization of $2.44 million and generates $3.87 million in revenue each year. American Bio Medica employs 41 workers across the globe.

What is American Bio Medica's official website?

The official website for American Bio Medica is http://www.abmc.com/.

How can I contact American Bio Medica?

American Bio Medica's mailing address is 122 SMITH ROAD, KINDERHOOK NY, 12106. The company can be reached via phone at 518-758-8158 or via email at [email protected]

MarketBeat Community Rating for American Bio Medica (OTCMKTS ABMC)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  32 (Vote Underperform)
Total Votes:  64
MarketBeat's community ratings are surveys of what our community members think about American Bio Medica and other stocks. Vote "Outperform" if you believe ABMC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABMC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel